Clinical Study:

Diarrhea:Interventional study ofBifidobacterium animalis subsp. lactisBLa80 in improving acute watery diarrhea in children

Constipation:Efficacy, safety, and acceptability of the probioticBifidobacterium animalis subsp. lactisBLa80 in regulating gut habits in chronic constipation patients

Anti-H. pylori:Effects of probiotics combined with bismuth quadruple therapy on the gut microbiota during eradication of Helicobacter pylori

Immune Boosting:Safety and efficacy ofBifidobacterium animalis subsp. lactisBLa80 in modulating gut microbiota and immune function: a randomized, double-blind, placebo-controlled clinical trial (in progress)

Relief of IBS-D:Randomized, double-blind, placebo-controlled trial investigating the effects ofBifidobacterium animalis subsp. lactisBLa80 on diarrhea-predominant irritable bowel syndrome (IBS-D) and gut microbiota modulation (in progress)

Patent:

CN114146101B

The Application ofBifidobacterium lactisBLa80 in the Production of Pharmaceuticals or Foods for Regulating Intestinal Motility.

CN114146100B

The Application ofBifidobacterium lactisBLa80 in the Production of Pharmaceuticals for Treating Rotavirus Infection-Induced Diarrhea.

CN113430133B

A Compound Probiotic for Alleviating Ulcerative Colitis, Preparation Method, and Its Application.

CN113265361B

A Compound Probiotic Preparation for Alleviating Non-Alcoholic Fatty Liver Disease, Preparation Method, and Its Application.

CN113913322B

The Application ofBifidobacterium lactisBLa80 in Alleviating Diarrhea and Enhancing Intestinal Immune Function.

CN113265361B

A Compound Probiotic Formulation for Alleviating Non-Alcoholic Fatty Liver Disease, Preparation Method, and Its Application.

SCI:

Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model.

BifdobacteriumBLa80 mitigates colitis by altering gut microbiota and alleviating infammation.

Application: